JP2023538984A5 - - Google Patents
Info
- Publication number
- JP2023538984A5 JP2023538984A5 JP2022563957A JP2022563957A JP2023538984A5 JP 2023538984 A5 JP2023538984 A5 JP 2023538984A5 JP 2022563957 A JP2022563957 A JP 2022563957A JP 2022563957 A JP2022563957 A JP 2022563957A JP 2023538984 A5 JP2023538984 A5 JP 2023538984A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- use according
- triiodothyronine
- administered
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20200100200 | 2020-04-21 | ||
| GR20200100200A GR1010068B (el) | 2020-04-21 | 2020-04-21 | Φαρμακευτικη συνθεση που περιεχει l-τριιωδοθυρονινη (τ3) για χρηση στη θεραπεια ασθενων σε κρισιμη κατασταση με λοιμωξη απο κορωνοϊο |
| GR20200100695 | 2020-11-23 | ||
| GR20200100695A GR1010182B (el) | 2020-11-23 | 2020-11-23 | Φαρμακευτικη συνθεση που περιεχει l-τριιωδοθυρονινη (τ3) για χρηση στην αντιμετωπιση της ιστικης υποξιας |
| GR20210100216 | 2021-03-29 | ||
| GR20210100216A GR1010261B (el) | 2021-03-29 | 2021-03-29 | Φαρμακευτικη συνθεση που περιεχει l-τριιωδοθυρονινη (τ3) για χρηση στην αντιμετωπιση της φλεγμονωδους αντιδρασης και της δυσλειτουργιας του καρδιαγγειακου συστηματος λογω σηψης |
| PCT/GR2021/000019 WO2021214497A1 (en) | 2020-04-21 | 2021-04-15 | Pharmaceutical composition comprising l-triiodothyronine (t3) for use in the treatment of tissue hypoxemia and sepsis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538984A JP2023538984A (ja) | 2023-09-13 |
| JP2023538984A5 true JP2023538984A5 (https=) | 2024-04-23 |
Family
ID=76197481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563957A Pending JP2023538984A (ja) | 2020-04-21 | 2021-04-15 | 組織低酸素症及び敗血症の治療に使用するためのｌ－トリヨードチロニン（ｔ３）を含む医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230157982A1 (https=) |
| EP (1) | EP4138810A1 (https=) |
| JP (1) | JP2023538984A (https=) |
| KR (1) | KR20230022839A (https=) |
| CN (1) | CN115996710B (https=) |
| AU (1) | AU2021258544A1 (https=) |
| BR (1) | BR112022021250A2 (https=) |
| CA (1) | CA3176106A1 (https=) |
| GE (2) | GEP20247706B (https=) |
| IL (1) | IL297398B1 (https=) |
| MX (1) | MX2022013228A (https=) |
| WO (1) | WO2021214497A1 (https=) |
| ZA (1) | ZA202212502B (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1942995A (en) * | 1994-03-15 | 1995-10-03 | K.U. Leuven Research & Development | New use of growth hormone |
| SI3908272T1 (sl) | 2019-01-09 | 2023-07-31 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | L-trijodotironin (t3) za uporabo pri omejevanju mikrovaskularne obstrukcije |
-
2021
- 2021-04-15 CA CA3176106A patent/CA3176106A1/en active Pending
- 2021-04-15 KR KR1020227039203A patent/KR20230022839A/ko active Pending
- 2021-04-15 JP JP2022563957A patent/JP2023538984A/ja active Pending
- 2021-04-15 CN CN202180029865.9A patent/CN115996710B/zh active Active
- 2021-04-15 IL IL297398A patent/IL297398B1/en unknown
- 2021-04-15 GE GEAP202116094A patent/GEP20247706B/en unknown
- 2021-04-15 WO PCT/GR2021/000019 patent/WO2021214497A1/en not_active Ceased
- 2021-04-15 AU AU2021258544A patent/AU2021258544A1/en active Pending
- 2021-04-15 EP EP21728969.3A patent/EP4138810A1/en active Pending
- 2021-04-15 MX MX2022013228A patent/MX2022013228A/es unknown
- 2021-04-15 BR BR112022021250A patent/BR112022021250A2/pt unknown
- 2021-04-15 US US17/920,171 patent/US20230157982A1/en active Pending
- 2021-04-15 GE GEAP202416094A patent/GEAP202416094A/en unknown
-
2022
- 2022-11-16 ZA ZA2022/12502A patent/ZA202212502B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2519660C2 (ru) | Режим дозировки селективного агониста рецептора s1p1 | |
| US20110195046A1 (en) | Erythropoietin ameliorates chemotherapy-induced toxicity in vivo | |
| AU2004216823B2 (en) | Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of IP-10 mediated diseases | |
| KR20030034177A (ko) | 허혈성 질환 치료제 | |
| WO2010012127A1 (zh) | 一种中药组合物在制备促进骨髓间质干细胞在体存活和成心肌分化的药物中的应用 | |
| JP5068253B2 (ja) | 心臓血管疾患の治療 | |
| JP2009539887A (ja) | 放射線肺障害の予防及び治療のためのピリドン系誘導体の使用 | |
| CN115463118A (zh) | 和厚朴酚在制备治疗或预防毛细血管瘤的药物中的用途 | |
| JP2023538984A5 (https=) | ||
| JP2013060447A (ja) | ボーラスまたは間欠的な静脈内注入による、抗内毒素薬の投与 | |
| CN121443295A (zh) | 治疗前列腺癌的方法 | |
| JP2005206544A (ja) | 筋肉再生剤 | |
| SPIES et al. | Vitamin B6 (Pyridoxin) Deficiency in Human Beings: Further Studies, with Special Emphasis on the Urinary Excretion of Pyridoxin | |
| Eisalo et al. | HAEMODYNAMIC EFFECTS OF TRASICOR®, A NEW BETA‐ADRENERGIC BLOCKING AGENT, IN HYPERTENSIVE PATIENTS | |
| CN112773796A (zh) | 醋甲唑胺在制备治疗1型糖尿病心肌病的药物中的应用 | |
| CN107737108B (zh) | 一种治疗心肌梗死后心室重塑的口服药物组合物 | |
| RU2200551C1 (ru) | Способ улучшения сократительной функции миокарда у больных с ишемической болезнью сердца | |
| CN1224396C (zh) | 一种用于治疗心脑血管疾病的药物 | |
| JP4965791B2 (ja) | 敗血症性ショックの治療方法 | |
| JP6838676B2 (ja) | 頻脈性不整脈の処置用の医薬組成物 | |
| RU2233658C1 (ru) | Способ профилактики кардиальных осложнений общей гипертермии с полихимиотерапией у больных с запущенными формами рака | |
| Toyama et al. | Low-dose and long-term G-CSF treatment can improve severe myocardial ischemia in patients with severe coronary artery disease | |
| CA2596768A1 (en) | A method for treating heart failure | |
| KR20240127999A (ko) | 심기능을 개선하기 위한 조성물 | |
| JP2004231557A (ja) | エピネフリン含有抗腫瘍剤 |